Thyrotoxic periodic paralysis: clinical features
Evidence-based neurology checklist on thyrotoxic periodic paralysis: clinical features: Genetics and pathology Kir2.6 gene mutations may occur It is associated with hyperthyroidism Features of thyrotoxicosis may be subtle Demographic features Prodromal features Features of weakness Drug triggers…
Genetics and pathology
- Kir2.6 gene mutations may occur
- It is associated with hyperthyroidism
- Features of thyrotoxicosis may be subtle
Demographic features
Prodromal features
Features of weakness
Drug triggers
Other triggers
Differential diagnosis
References
- Finsterer J. Primary periodic paralyses. Acta Neurol Scand 2008; 117:145-158.
- Kung AW. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab 2006; 91:2490-2495.
- Lulsegged A, Wlodek C, Rossi M. Thyrotoxic periodic paralysis: case reports and an up-to-date review of the literature. Case Rep Endocrinol 2011; 2011:867475.
- Scheive M, Patel N, Saeed Z. High-dose intravenous hydrocortisone for the treatment of hyperthyroidism: a rare precipitant of thyrotoxicosis periodic paralysis. Endocrinol Diabetes Metab Case Rep 2023; 2023:22-0358.
- Batra J, Ankireddypalli A, Kanugula AK, Gorle S, Kaur J. Thyrotoxic periodic paralysis with severe hypokalemia precipitated by acute alcohol intoxication in a patient with Graves' disease. Cureus 2023; 15:e35548.
- And 5 more. Subscribe to see the full list
